HealthDay - WEDNESDAY, July 27 (HealthDay News) -- Intensive glucose-lowering treatment for people with type 2 diabetes doesn't reduce the risk of cardiovascular-related death and doctors need to be cautious about prescribing this type of treatment, a new study suggests.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.